Related Experiment Video

Updated: Jul 31, 2026

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

Left ventricular hypertrophy in hypertension

F G Dunn1, J M Burns, R S Hornung

  • 1Department of Medical Cardiology, Stobhill General Hospital, Glasgow, United Kingdom.

American Heart Journal
|July 1, 1991
PubMed

Insights

Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular disease in hypertensive patients. Antihypertensive drugs, including nicardipine, can cause LVH regression, but long-term benefits require further study.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiovascular Disease

Background:

  • Left ventricular hypertrophy (LVH) is an independent risk factor for cardiovascular disease.
  • Hypertension is a major cause of LVH, increasing the risk of coronary artery disease and myocardial ischemia.
  • Echocardiography has improved the diagnosis of LVH.

Purpose of the Study:

  • To understand the interrelationships between hypertension and LVH.
  • To review the mechanisms of sudden death in patients with LVH.
  • To assess the efficacy of antihypertensive drugs in LVH regression.

Main Methods:

  • Review of recent advances in echocardiography for LVH diagnosis.
  • Analysis of studies on the relationship between hypertension, LVH, and cardiovascular events.
  • Evaluation of data on antihypertensive drug effects on LVH regression.

Main Results:

  • LVH is a critical independent risk factor for cardiovascular disease, particularly in hypertensive individuals.
  • The hypertrophied left ventricle is susceptible to myocardial ischemia.
  • Several antihypertensive drugs, including beta-blockers, ACE inhibitors, and nicardipine, promote LVH regression without impairing left ventricular function.

Conclusions:

  • Understanding the link between hypertension and LVH is crucial for cardiovascular risk management.
  • LVH regression is achievable with certain antihypertensive medications.
  • Further research is necessary to determine the long-term clinical benefits of LVH regression.

More Related Videos

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...